ANDA 86329, held by Ivax Pharms. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 86329 (Phentermine Hydrochloride), held by Ivax Pharms, was first approved by FDA on Dec 8, 1978, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 8, 1978 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phentermine Hydrochloride30MG ยท capsule;oral | Phentermine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters